2DG reduces a patient's average recovery time by two and a half days and oxygen demand by up to 40%.
A higher proportion of patients treated with 2-DG have shown RT-PCR negative conversion in COVID patients.
The 2DG drug is strictly prohibited for use in pregnant and lactating women, and those below 18 years.
2DG is an oral ani-viral drug that can be administered only upon prescription to hospitalised moderate to severe Covid-19 patients as add on therapy a